Acurx Pharmaceuticals, Inc. (ACXP)
USD 0.72
(-16.62%)
USD 0.72
(-16.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -9.8 Million | -7.54 Million | -5.01 Million | -3.35 Million | -3.98 Million |
| Net Income | -14.57 Million | -12.09 Million | -12.74 Million | -4.6 Million | -5.93 Million |
| Depreciation & Amortization | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 3.76 Million | 3.3 Million | 6.74 Million | 1.26 Million | 900.43 Thousand |
| Change in working capital | 1.01 Million | 1.24 Million | 141.28 Thousand | -801.16 Thousand | 1.04 Million |
| Other non-cash items | 559.58 Thousand | 3.3 Million | 850.26 Thousand | 781.7 Thousand | 900.43 Thousand |
| Investing Cash Flow | - | - | - | - | - |
| Investments in PPE | 5.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 8.16 Million | 3.69 Million | 14.79 Million | 4.04 Million | 4.45 Million |
| Debt repayment | - | - | - | -66.5 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 5.94 Million | 3.69 Million | 14.79 Million | 3.97 Million | 4.45 Million |
| Other Financing Activities | 2.21 Million | 13.00 | 14.79 Million | 133 Thousand | 454.98 Thousand |
| Accounts receivables | -129.15 Thousand | - | - | - | - |
| Accounts payables | 980.75 Million | 1.21 Million | 387.97 Million | - | - |
| Inventory | -980.75 Million | - | - | - | - |
| Other working capital | 1.13 Million | 30.34 Thousand | -387.83 Million | -801.16 Thousand | 1.04 Million |
| Cash at beginning of period | 9.11 Million | 12.95 Million | 3.17 Million | 2.48 Million | 2.01 Million |
| Cash at end of period | 7.47 Million | 9.11 Million | 12.95 Million | 3.17 Million | 2.48 Million |
| Capital Expenditure | 5.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -1.63 Million | -3.84 Million | 9.78 Million | 692.08 Thousand | 470.16 Thousand |
| Free Cash Flow | -9.8 Million | -7.54 Million | -5.01 Million | -3.35 Million | -3.98 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.12 Million | -4.37 Million | -5.11 Million | -14.57 Million | -3.11 Million | -3.44 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.23 Million | 1.2 Million | 1.22 Million | 3.76 Million | 833.28 Thousand | 806.48 Thousand |
| Change in working capital | 11.04 Thousand | 114.83 Thousand | -310.15 Thousand | 1.01 Million | 188.19 Thousand | 1.06 Million |
| Other non-cash items | 1.28 Million | 1.07 Million | 393.68 Thousand | 559.58 Thousand | 833.28 Thousand | 806.48 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 320.21 Thousand | 4.5 Million | 4.61 Million | 8.16 Million | - | 3.54 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 320.21 Thousand | 4.29 Million | 2.4 Million | 5.94 Million | - | 3.54 Million |
| Other Financing Activities | 320.21 Thousand | 210.19 Thousand | 2.21 Million | 2.21 Million | - | 73.00 |
| Accounts receivables | -51.12 Thousand | 129.15 Thousand | - | -129.15 Thousand | - | - |
| Accounts payables | - | 67.8 Million | 968.45 Million | 980.75 Million | - | - |
| Inventory | - | - | - | -980.75 Million | - | - |
| Other working capital | 62.17 Thousand | -14.32 Thousand | -310.15 Thousand | 1.13 Million | 188.19 Thousand | 1.06 Million |
| Cash at beginning of period | 8.92 Million | 7.47 Million | 7.05 Million | 9.11 Million | 9.14 Million | 7.17 Million |
| Cash at end of period | 6.36 Million | 8.92 Million | 7.47 Million | 7.47 Million | 7.05 Million | -1.57 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.56 Million | 1.44 Million | 421.85 Thousand | -1.63 Million | -2.09 Million | -8.75 Million |
| Free Cash Flow | -2.88 Million | -3.06 Million | -4.19 Million | -9.8 Million | -2.09 Million | -1.57 Million |
8542
VUL
E8X
BBN
000660
002611